Nan Fung Group Holdings Ltd — 13F Holdings & Portfolio

CIK 1782539 · latest 13F-HR filed 2026-11-13

Nan Fung Group Holdings Ltd manages $149.7M in 13F-reported U.S. long-equity assets across 29 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are LBRX (16.17%), MPLT (15.66%), OBX (8.43%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 5 new positions and exited 1; 10 existing positions rose in reported value and 10 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$149.7M

Long-equity book

Holdings
29

Distinct positions

Period
2026-09-30

Filed 2026-11-13

Q/Q Activity
+5 / −1 / ↑10 / ↓10

vs 2026-06-30

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q3 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q2 26 → Q3 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

5 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 75.7%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

Name Title / Status Ownership Type

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Nan Fung Group Holdings Ltd Holdings (2026-09-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 LB PHARMACEUTICALS INC LBRX 50180M108 $24.2M 16.17% 630,657 SH
2 MAPLIGHT THERAPEUTICS INC MPLT 56565P103 $23.4M 15.66% 2,300,328 SH
3 OBSIDIAN THERAPEUTICS INC OBX 67448A106 $12.6M 8.43% 918,765 SH
4 CYBIN INC HELP 23256X407 $12.1M 8.11% 987,222 SH
5 EVOMMUNE INC EVMN 30054Y107 $11.9M 7.95% 1,441,032 SH
6 NUVATION BIO INC NUVB 67080N101 $7.4M 4.97% 1,327,224 SH
7 INCYTE CORP INCY 45337C102 $6.5M 4.36% 53,742 SH
8 BEONE MEDICINES LTD ONC 07725L102 $5.8M 3.84% 15,722 SH
9 RHYTHM PHARMACEUTICALS INC RYTM 76243J105 $4.7M 3.12% 49,120 SH
10 PROCORE TECHNOLOGIES INC PCOR 74275K108 $4.6M 3.07% 88,832 SH
11 NEWAMSTERDAM PHARMA COMPANY NAMS N62509109 $4.0M 2.68% 164,986 SH
12 REVOLUTION MEDICINES INC RVMD 76155X100 $4.0M 2.64% 19,253 SH
13 KYMERA THERAPEUTICS INC KYMR 501575104 $3.5M 2.31% 30,875 SH
14 ASCENDIS PHARMA A/S ASND K08588103 $3.1M 2.07% 13,600 SH
15 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $2.9M 1.91% 5,672 SH
16 OCULIS HOLDING AG OCS H5870P102 $2.8M 1.88% 300,565 SH
17 ARGENX SE ARGX 04016X101 $2.7M 1.79% 2,800 SH
18 TCGX ACQUISITION CORP TCGX G8708J109 $2.5M 1.67% 200,000 SH
19 CELCUITY INC CELC 15102K100 $2.3M 1.50% 28,300 SH
20 ACADIA PHARMACEUTICALS INC ACAD 004225108 $2.1M 1.39% 102,984 SH
21 BRAVEHEART BIO INC BRVE 10567X101 $1.6M 1.10% 81,376 SH
22 HARMONY BIOSCIENCES HLDGS IN HRMY 413197104 $1.1M 0.71% 27,049 SH
23 ISHARES ETHEREUM TR ETHA 46438R105 $1.0M 0.68% 50,549 SH
24 ISHARES BITCOIN TRUST ETF IBIT 46438F101 $755.9K 0.51% 15,968 SH
25 INSMED INC INSM 457669307 $751.0K 0.50% 6,580 SH
26 RECURSION PHARMACEUTICALS IN RXRX 75629V104 $750.1K 0.50% 181,631 SH
27 RANI THERAPEUTICS HLDGS INC RANI 753018100 $390.4K 0.26% 493,584 SH
28 ENTRADA THERAPEUTICS INC TRDA 29384C108 $311.7K 0.21% 49,082 SH
29 BOLT BIOTHERAPEUTICS INC BOLT 097702203 $18.4K 0.01% 5,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-09-30 2026-11-13 $149.7M 29 0001012975-26-001047
2026-06-30 2026-08-13 $131.5M 25 0001012975-26-000761
2026-03-31 2026-05-14 $121.3M 24 0001012975-26-000423
2025-12-31 2026-02-13 $111.7M 27 0001012975-26-000144
2025-09-30 2025-11-13 $59.6M 24 0001012975-25-000750
Filer Information
Address
17TH FLOOR, AIRSIDE
2 CONCORDE ROAD
KAI TAK, K3 00000
Phone
852-2521-7417
Filing Manager
Nan Fung Group Holdings Ltd
KAI TAK, K3
Signatory
Tang Chun Wai Nelson
Director